Live Breaking News & Updates on Vanderbilt vaccine research program

Stay informed with the latest breaking news from Vanderbilt vaccine research program on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Vanderbilt vaccine research program and stay connected to the pulse of your community

INSIS study unveils secrets of rare vaccine events, shaping future immunizations

A University of Alberta professor is co-leading a new international vaccine safety network to examine why some people who received a COVID-19 vaccine experienced very rare adverse events associated with the vaccine.

Boston , Massachusetts , United-states , Italy , India , New-zealand , Australia , Robertt-chen , Ospedale-pediatrico-bambino , Jakob-cramer , Bc-children-hospital-research-institute , University-of-alberta

More Data Back Guillain-Barré Risk With Janssen COVID Shot

Observed cases of Guillain-Barré syndrome after receipt of the Janssen shot were two to three times greater than background rates within 3-6 weeks of vaccination, new US surveillance data show.

California , United-states , Tennessee , Oakland , Vanderbilt-university , Winston-abara , Kaiser-permanente , Nicola-klein , Vanderbilt-vaccine-research-program , Medscape-coronavirus-resource-center , Us-centers-for-disease , Advisory-committee-on-immunization-practices

Myocarditis Appears Rare After COVID-19 Vaccination

Clinicians should consider age, sex, and vaccine type when accounting for vaccination risks, according to the authors of an observational study.

Tennessee , United-states , Canada , United-kingdom , Vanderbilt-university , Vancouver , British-columbia , British , Canadian , Naveed-janjua , Centers-for-disease , Vanderbilt-vaccine-research-program

Moderna's COVID-19 vaccine safe and effective in children 6 months to 5 years of age

Moderna's COVID-19 vaccine is safe and effective in children 6 months to 5 years of age, a clinical trial co-led by Vanderbilt University Medical Center vaccine expert C. Buddy Creech, MD, MPH, has found.

United-states , Canada , Robert-califf , Vladimir-berthaud , Edie-carell-johnson , Evan-anderson , Emily-henderson , Vanderbilt-university-medical-center , Vanderbilt-vaccine-research-program , Biomedical-advanced-research , National-institutes-of-health , Emory-university-school-of-medicine

V-Safe data: Around 782,900 Americans sought medical attention and hospitalization following COVID-19 vaccination

Around 782,900 Americans were reported to have sought medical attention, emergency room care and/or hospitalization following their Wuhan coronavirus (COVID-19) vaccination. Another 2.5 million [...]

Wuhan , Hubei , China , United-states , Americans , Robert-pitman , Kathryn-edwards , Aaron-siri , Centers-for-disease , Pfizer , Vanderbilt-vaccine-research-program , Clinical-immunization-safety-assessment-network